Cytosorbents (CTSO)
(Delayed Data from NSDQ)
$0.80 USD
0.00 (0.12%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $0.82 +0.02 (2.24%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.12 |
Last EPS Surprise | 14.29% |
ABR | 1.67 |
Earnings ESP
|
8.33% |
---|---|
Current Year | -0.36 |
Next Year | -0.17 |
EPS (TTM) | -0.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.78M | 9.85M | 40.29M | 47.75M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 10.20M | 10.34M | 41.30M | 49.76M |
Low Estimate | 9.00M | 9.40M | 39.51M | 44.10M |
Year ago Sales | 9.45M | 9.42M | 36.35M | 40.29M |
Year over Year Growth Est. | 3.52% | 4.52% | 10.85% | 18.51% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.10 | -0.36 | -0.17 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.11 | -0.10 | -0.34 | -0.09 |
High Estimate | -0.10 | -0.07 | -0.31 | -0.09 |
Low Estimate | -0.15 | -0.12 | -0.43 | -0.26 |
Year ago EPS | -0.17 | -0.14 | -0.64 | -0.36 |
Year over Year Growth Est. | 29.41% | 28.57% | 43.75% | 52.78% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.10 | -0.36 | -0.17 |
7 Days Ago | -0.12 | -0.10 | -0.36 | -0.17 |
30 Days Ago | -0.13 | -0.10 | -0.46 | -0.21 |
60 Days Ago | -0.13 | -0.11 | -0.48 | -0.21 |
90 Days Ago | -0.13 | -0.11 | -0.48 | -0.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.10 | -0.34 | -0.09 |
Zacks Consensus Estimate | -0.12 | -0.10 | -0.36 | -0.17 |
Earnings ESP | 8.33% | -3.45% | 5.56% | 47.06% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.12 | -0.21 | -0.14 | -0.17 | NA |
Estimate | -0.14 | -0.12 | -0.11 | -0.13 | NA |
Difference | 0.02 | -0.09 | -0.03 | -0.04 | -0.04 |
Surprise | 14.29% | -75.00% | -27.27% | -30.77% | -29.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more